First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.
Journal of Psychopharmacology February 18, 2021 Ben Sessa, Laurie Higbed, Steve O’Brien et al. 123 citations
Background: 3,4-methylenedioxymethamphetamine (MDMA) therapy has qualities that make it potentially well suited for patients with addictions, but this has never been explored in a research study. We present data from the Bristol Imperial MDMA in Alcoholism (BIMA) study. This is the first MDMA addiction study, an open-label safety and tolerability proof-of-concept study investigating the...
DOI: 10.1177/0269881121991792 (opens in new tab)
Alcohol use disorder
Aud
Alcoholism
Alcohol addiction
+19